UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...

The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...

Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...

Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...